A

Apellis Pharmaceuticals
D

APLS

30.760
USD
3.02
(10.89%)
Market Closed
Volume
118,447
EPS
-2
Div Yield
-
P/E
-15
Market Cap
3,826,329,203
OverviewSignalsIdeasNews
Related Instruments
    A
    ABUS
    0.01000
    (0.28%)
    3.64000 USD
    AMGN
    AMGN
    -12.22
    (-4.13%)
    294.4 USD
    A
    ANAB
    -1.150
    (-5.69%)
    19.060 USD
    A
    ARWR
    -2.890
    (-13.49%)
    18.540 USD
    A
    ATNX
    -0.34000
    (-19.65%)
    1.43000 USD
    B
    BGNE
    -4.220
    (-2.18%)
    189.320 USD
    BIIB
    BIIB
    -4.840
    (-2.94%)
    160.000 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    C
    CRBP
    -0.950
    (-5.41%)
    16.610 USD
    E
    EXEL
    -0.600
    (-1.71%)
    34.450 USD
    GE
    GE
    -1.530
    (-0.86%)
    181.11 USD
    GSK
    GSK
    -1.020
    (-2.97%)
    33.350 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    More
News

Title: Apellis Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.